Ruboxistaurin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review of Randomized Clinical Trials

BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. Protein kinase C (PKC) inhibitor's has been thought to be a potential disease modifying drug's in DPN as it slows or reverse neuropathy's progression. To assesses the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, Dipika, Badhan, Yogesh, Gudala, Kapil, Schifano, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816139/
https://www.ncbi.nlm.nih.gov/pubmed/24199167
http://dx.doi.org/10.4093/dmj.2013.37.5.375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816139/
https://www.ncbi.nlm.nih.gov/pubmed/24199167
http://dx.doi.org/10.4093/dmj.2013.37.5.375

Ejemplares similares